31 employees
Ascus Biosciences uses novel microbial community screening methods to discover, develop, and commercialize next generation feed additives.
2015
$46M
from 4 investors over 4 rounds
Ascus Biosciences raised $46M on May 27, 2020
Investors: Anterra Capital, Cavallo Ventures, Formation 8 and Temasek